Compliance in Hemodialysis Patients: Unanticipated Monitoring of Biochemical Indices
|
|
- Buddy Morton
- 6 years ago
- Views:
Transcription
1 Original Paper Blood Purif 1998;16: Accepted: September 23, 1998 Mustafa Arici Bülent Altun Celalettin Usalan Sükrü Ulusoy Yunus Erdem Ünal Yasavul Çetin Turgan Sali Çaglar School of Medicine, Department of Internal Medicine, Division of Nephrology and Hemodialysis Center, Hacettepe University, Ankara, Turkey OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Key Words Compliance Hemodialysis Biochemical measures Compliance in Hemodialysis Patients: Unanticipated Monitoring of Biochemical Indices OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Abstract Compliance with the prescribed medical regimen is a critical factor for the continued well-being of hemodialysis patients. As compliance is a multifactorial problem, numerous approaches have been utilized to quantify the compliance of hemodialysis patients. In the present study, we have attempted to examine whether unanticipated control of biochemical indices might predict the compliance status of hemodialysis patients. We compared unanticipated mid-month values of blood urea nitrogen (BUN), serum potassium (K) and phosphate (PO 4 ) values of 54 maintenance hemodialysis patients with the scheduled, regular first- measurements during a 6-month study period. The interdialytic weight gain (IWG) levels of the corresponding s were also compared. Mid-month analysis revealed a significant deviation in the compliance status of the study population as BUN, serum K and IWGs were concerned (p! 0.05). The mid-month serum PO 4 levels were also higher but the difference was not significant (p! 0.05). In conclusion, the differences observed in biochemical indices upon change of test request timing were distinctive. It suggests that unanticipated control of biochemical indices might contribute to the actual assessment of compliance in hemodialysis patients. OOOOOOOOOOOOOOOOO ABC Fax karger@karger.ch S. Karger AG, Basel /98/ $17.50/0 Accessible online at: Yunus Erdem, MD Hacettepe Hastanesi, Nefroloji Bolumu TR Sihhiye/Ankara, (Turkey) Tel , Fax hunephro@superonline.com
2 Introduction Few chronic treatment plans are as complex and difficult as those prescribed for chronic hemodialysis (HD) patients. The frequency and duration of HD, alterations in life-style, physical and psychosocial deprivations, multiple medication needs, episodic access procedures and various other testing and hospitalization requirements are components of every patient s treatment regimen. Hence, successful treatment of a patient in the HD setting requires not only a mathematically adequate dialysis but the appropriate cooperation of the patient in that he has to maintain a strict diet, control fluid intake and comply to medication instructions [1 3]. As compliance is a multifaceted problem, numerous approaches have been utilized in order to quantify the noncompliance of HD patients with dietary and medication prescriptions [4]. The commonest sources of data for adherence to medications and dietary restrictions are sequential values of biochemical indices [5] which have direct implications for health outcome. The frequently used measures are interdialytic weight gain (IWG), as an index of compliance for fluid intake, predialysis serum potassium (K) and blood urea nitrogen (BUN) as measures of dietary compliance and serum phosphate (PO 4 ) as a parameter for medication intake [6, 7]. These parameters are commonly considered to be more reliable and less biased than other measures of compliance such as staff or patient self-reports [8, 9]. Though test request patterns might differ from one center to another [10], the majority of HD centers obtain regular monthly clinical chemistry tests for patients on maintenance treatment [11]. As patients were accustomed to be monitored on a regular basis, the shift in the test request time might distinguish the variations in compliance behavior. In the present study, we have attempted to examine whether unanticipated control of biochemical indices and IWG, instead of the values obtained on a regular basis, might contribute to the assessment of compliance status of chronic HD patients. Patients and Methods The study was conducted in Hacettepe University Outpatient Dialysis Center. All patients, except those with a daily urine volume of more than 100 ml, with a known psychiatric disorder, hospitalized for any reason and receiving a transplant during the study period, were included in the study. A total of 54 patients was qualified for the study. The sociodemographic data including age, sex, and duration of dialysis treatment were obtained from medical chart reviews. All patients were hemodialyzed for 5 h, three times ly, using Cuprophan hollow-fiber dialyzers and a dialysate K content of 2 meq/l. Blood flow was usually maintained at 250 ml/min and dialysate flow was 500 ml/min. The delivered dose of dialysis was calculated monthly according to Daugirdas single-pool Kt/V model [12]. Serum albumin values were recorded monthly for assessing patients nutritional status. All patients were on calcium carbonate as phosphate binder. In the center, a multiple-test laboratory panel (including BUN, creatinine, electrolytes, calcium, phosphorus, liver enzymes, albumin and lipid profile) and complete blood count are obtained in the first of each month before a mid- dialysis session. Nutritional assessment is also performed on a monthly basis and patients receive monthly dietary advice. The IWG, however, is controlled in each session and managed appropriately. The data related to iron status, parathyroid hormone levels and hepatitis surveillance tests are also assessed periodically in the first of each month with regular intervals. An attending nephrologist evaluates the predialysis laboratory values and makes recommendations related to overall health status, fluid and dietary intake and medication usage in the first of each month. As measures of compliance, predialysis serum K, PO 4, BUN and IWGs were analyzed. All measurements were done just before initiation of a mid- dialysis session. Instead of defining categories of compliance as low, moderate or high, we used laboratory parameters as continuous ordinal variables 276 Blood Purif 1998;16: Arici/Altun/Usalan/Ulusoy/Erdem/ Yasavul/Turgan/Çaglar
3 [1, 6]. Compliance data were calculated from the monthly laboratory test results of the consecutive 6 months (the values were summed and divided for average values) and compared with the unexpected laboratory assessment performed in the mid-month of second and fifth months of the study period (the average of two values was used). The IWGs were estimated as the increase in weight gain between the end of the first and beginning of the second ly dialysis in the first of each month and compared with IWGs observed during unanticipated laboratory assessment period. Statistical Analysis Data were expressed as mean B SD. Statistical analysis was performed using the paired-samples t test. The relationship between variables was analyzed by Spearman correlation coefficients. p! 0.05 was considered statistically significant. The data were analyzed using SPSS v 6.0 for Windows (SPSS Inc.). the first of each month (1,608 B 609 g, p! 0.05). The mean arterial pressure values were also higher in mid-month period although the difference was not statistically significant. The serum PO 4 levels were increased in the mid-month analysis (5.33 B 1.67 versus 4.96 B 1.52 mg/dl); however, the difference was not statistically significant (p ) (fig. 1). A moderate positive correlation between age of the patients and the difference in the serum PO 4 values (r = 0.30, p! 0.05) was observed. No other significant correlation was present between study variables and the sociodemographic characteristics of the patients. Results The 54 patients included 35 males and 21 females. The mean age of the patients at time of the study was 40 B 12 years (range 18 70). Mean time on dialysis was 91 B 50 months (range 6 233). During the 6-month study period, the monthly Kt/V values were stable with a mean of 1.26 B 0.04 and exhibited no significant alteration from month to month. The serum albumin values were also in normal limits (3.93 B 0.36 g/dl) with no major change. The mean mid-month BUN level was 72.7 B 14.2 mg/dl and significantly higher than the mean BUN level obtained in the first (64.9 B 11.2 mg/dl, p! 0.001). A significant increase was also observed in mean serum K levels in the mid-month analysis compared with the values obtained in regular first- examinations (5.60 B 0.70 versus 5.05 B 0.91 meq/l, p! 0.001). The IWG values during the mid-month period were 1,766 B 672 g and they were significantly higher than the values observed in Discussion Compliance behavior is difficult to address in end-stage renal disease, however must be dealt with in planning care, particularly for long-term maintenance dialysis patients. Numerous studies have attempted to investigate factors associated with inadequate adherence and many cognitive and emotional variables, behavioral patterns, health beliefs and sociodemographic parameters were assigned as predictors of noncompliance [13]. However, cognitive and behavioral factors rather than demographic characteristics were found to be major determinants of compliance in most studies. Social support, personality variables, psychological distress, patient-staff relationships and even minor ly stresses were all previously demonstrated to alter the biochemical measures of compliance [4, 5, 9, 14]. As two recent studies put forward the close relationship between compliance and survival [2, 3], there is little doubt that the evaluation and control of confounding factors for compliance is essential for the proper management of HD treatment. Compliance in Hemodialysis Patients Blood Purif 1998;16:
4 BUN (mg/dl) K (meq/l) a First 100 a First Midmonth 4.6 Midmonth Fig. 1. BUN, serum K, serum PO 4 and IWG values obtained in the first s of a 6-month study period and mid-month values obtained in the second and fifth months. Values were expressed as mean B SD. a p! 0.001, b p! 0.05, c not significant (mid-month versus first ). IWG (g) 1,900 b 5.6 1, PO (mg/dl) 1, , , First c 1,400 First Midmonth 4.6 Midmonth In the present study, we observed a significant deviation in the compliance status of the study population as mid-month biochemical measures were concerned. We noticed a decrease in the compliance status of dietary adherence as mid-month BUN and K levels displayed higher predialysis levels. Even though the IWGs of our patients were not in extreme limits when compared with a large survey of US patients [3], the difference between mid-month and first- values (1,766 B 672 versus 1,608 B 609 g) is noticeable and implies a change in fluid and/or salt intake. The variations in MAP values were also in accordance with the difference observed in IWGs. The nonsignificant increase in predialysis serum PO 4 values might indicate that medication compliance was altered but not as much as dietary and fluid restriction parameters. The present findings with regard to the lack of significant relationships between altered compliance and sociodemographic variables are compatible with previous reports. However, it could not be possible to reach satisfactory relationships as we have evaluated a relatively small number of patients (54 patients) within a limited time period (6 months). The only significant relationship was between the age of the patients and the differences observed in predialysis serum PO 4 levels. This could be attributed to the occurrence of memory deficits in the elderly population. In a previous study, the compliance status of the elderly population was less impressive with regard to predialysis serum PO 4 levels compared to K values [15]. The main clinical relevance of the present study is the observation of alterations in the compliance status when biochemical indices are monitored in an unanticipated setting. This could be associated with the alterations in behavioral characteristics of the patient population. It was known that ritual versus reasoned compliance or passive versus active types of adherence to treatment regimen might affect compliance parameters. Ritual or passive compliance is a relatively inflexible 278 Blood Purif 1998;16: Arici/Altun/Usalan/Ulusoy/Erdem/ Yasavul/Turgan/Çaglar
5 behavior, in which the patient follows the prescribed regimen strictly without any modifications. However, reasoned or active compliance migh have some flexibility to accommodate the individual s day-to-day circumstances [16]. The predictors of such behaviors have not settled, but patients with the reasoned compliance behavior can learn to manipulate the system. In a 9-year study, O Brien observed a decrease in compliance of many individuals in a re-interview performed 3 years after the first interview. This finding was attributed to the decrease in ritual compliance and initiating a reasoned compliance; however, it might bring the danger of handling the system beyond the acceptable boundaries of active treatment compliance [16]. The unanticipated control of biochemical indices might uncover the deviation in behavioral patterns of compliance in HD patients. Patients might prepare themselves for the control periods and then alter their adherence characteristics. Some still manage their day-to-day requirements without jeopardizing fluid and electrolyte balance; however, some individuals expand the flexibility of reasoned compliance into a dangerous zone. Such in alteration could be associated with increased morbidity, even mortality like the behavior of skipping an HD session [3]. However, the probable deviation in the behavioral pattern of our study population should be assessed with the inclusion of emotional and cognitive attitudes of the patients and monitoring style of the hospital staff [17]. In summary, the majority of compliance data depends on monthly laboratory measures and the difference observed upon shift of test request timing was distinctive. This serves to indicate not only the importance of establishing more appropriate methodological instruments in studies of compliance, but also the probable effect of altered behavioral characteristics on compliance parameters. Insight into mechanisms and consequences of such differences might provide additional means for the actual assessment and managing problems of compliance in patients on chronic HD treatment. Acknowledgments We are grateful to nursing staff of the hemodialysis unit for cooperating in this study. We also appreciate volunteer participation of our patients. This work was presented, in part, at the XXXVth Congress of the European Renal Association European Dialysis and Transplant Association, Rimini, Italy, 6 9 June OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO References 1 Morduchowicz G, Sulkes J, Aizic S, Gabbay U, Winkler J, Boner G: Compliance in hemodialysis patients: A multivariate regression analysis. Nephron 1993;64: Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH: Psychological factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 1998;54: Leggat JE, Orzol SM, Hulbert-Shearon TE, Golber TA, Jones CA, Held PJ, Port FK: Noncompliance in hemodialysis: Predictors and survival analysis. Am J Kidney Dis 1998;32: Manley M, Sweeney J: Assessment of compliance in hemodialysis adaptation. J Psychosom Res 1986;30: Sensky T, Leger C, Gilmour S: Psychosocial and cognitive factors associated with adherence to dietary and fluid restriction regimens by people on chronic haemodialysis. Psychother Psychosom 1996;65: Ferraro KF, Dixon RD, Kinlaw BJR: Measuring compliance among in-center hemodialysis patients. Dial Transplant 1986;15: Compliance in Hemodialysis Patients Blood Purif 1998;16:
6 7 Simmens S, Kimmel PL, Kobrin S, Reiss D: Multidimensional assessment of compliance in two dialysis units. J Am Soc Nephrol 1991;2: Blackburn SL: Dietary compliance of chronic hemodialysis patients. J Am Diet Assoc 1977;70: Hitchcock PB, Brantley PJ, Jones GN, McKnight GT: Stress and social support as predictors of dietary compliance in hemodialysis patients. Behav Med 1992;18: Gardner MD, Henderson AR: Testrequest patterns for clinical chemistry in a British and Canadian Renal dialysis unit. Clin Chem 1983;29: Dillingham MA, Anderson RJ: Selected health care maintenance policies in chronic dialysis centers. Am J Kidney Dis 1985;6: Daugirdas JT: Second generation logarithmic estimates of single pool variable volume of Kt/V: An analysis of causes and an approach to evaluation. J Am Soc Nephrol 1993; 4: Hoover H: Compliance in hemodialysis patients: A review of the literature. J Am Diet Assoc 1989;89: Schneider MS, Friend R, Whitaker P, Wadhwa NK: Fluid noncompliance and symptomatology in endstage renal disease: Cognitive and emotional variables. Health Psychol 1991;10: McKevitt PM, Jones JF, Lane DA, Marion RR: The elderly on dialysis: Some considerations in compliance. Am J Kidney Dis 1990;16: O Brien ME: Compliance behavior and long-term maintenance dialysis. Am J Kidney Dis 1990;15: Christensen AJ, Moran PJ, Lawton WJ, Stallman D, Voigts AL: Monitoring attentional style and medical regimen adherence in hemodialysis patients. Health Psychol 1997;16: Blood Purif 1998;16: Arici/Altun/Usalan/Ulusoy/Erdem/ Yasavul/Turgan/Çaglar
Non-Compliance to Diet and Fluid Restrictions in Haemodialysis Patients
Non-Compliance to Diet and Fluid Restrictions in Haemodialysis Patients Abstract Pages with reference to book, From 293 To 295 Nilofer Safdar, Humera Baakza, Haren Kumar, S. A. J. Naqvi ( The Kidney Centre,
More informationOriginal Article. Introduction
Nephrol Dial Transplant (2004) 19: 100 107 DOI: 10.1093/ndt/gfg418 Original Article Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Serum phosphate GUIDELINES
Date written: August 2005 Final submission: October 2005 Author: Carmel Hawley Serum phosphate GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationImprovement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis
Advances in Peritoneal Dialysis, Vol. 24, 2008 Matthew J. Novak, 1 Heena Sheth, 2 Filitsa H. Bender, 1 Linda Fried, 1,3 Beth Piraino 1 Improvement in Pittsburgh Symptom Score Index After Initiation of
More informationDietary and fluid adherence among haemodialysis patients attending public sector hospitals in the Western Cape
Dietary and fluid adherence among haemodialysis patients attending public sector hospitals in the Western Cape Objective D Fincham, MA, A Kagee, PhD, MPH Department of Psychology, Stellenbosch University
More informationTaking Care of Your Kidneys
Taking Care of Your Kidneys Part A Roseville & Sacramento Medical Centers Health Promotion Department Nutritional Services Agenda Slide How your kidneys work Explaining chronic kidney disease Protecting
More informationDietary Adherence in Hispanic Patients Receiving Hemodialysis
Dietary Adherence in Hispanic Patients Receiving Hemodialysis Claudia Morales López, MS, RD, CDN,* Jerrilynn D. Burrowes, PhD, RD, CDN,* Frances Gizis, PhD, RD,* and Deborah Brommage, MS, RD, CSR, CDN
More informationPhosphate Management Guideline for Patients Receiving Extended Duration Hemodialysis
IAMHD HOME HEMODIALYSIS CLINICAL PRACTICE STANDARDS AND PROCEDURES Phosphate Management Guideline for Patients Receiving Extended Duration Hemodialysis PRINTED copies of Clinical Practice Standards and
More informationAJNT. Original Article
. 2012 May;5(2):81-6 Original Article AJNT Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis Sarra Elamin
More informationTHE HEMODIALYSIS PRESCRIPTION: TREATMENT ADEQUACY GERALD SCHULMAN MD VANDERBILT UNIVERSITY MEDICAL SCHOOL NASHVILLE, TENNESSEE
THE HEMODIALYSIS PRESCRIPTION: TREATMENT ADEQUACY GERALD SCHULMAN MD VANDERBILT UNIVERSITY MEDICAL SCHOOL NASHVILLE, TENNESSEE THE DIALYSIS CYCLE /TIME DESIGN OF THE NATIONAL COOPERATIVE DIALYSIS STUDY
More informationPlasma sodium as a predictor of death and non-osmotic sodium storage
An update on sodium in CKD stage 5D Plasma sodium as a predictor of death and non-osmotic sodium storage Prof. Mustafa ARICI, MD Hacettepe University Faculty of Medicine Ankara-TURKEY 2 (new) questions...
More informationPrincipal Equations of Dialysis. John A. Sweeny
Principal Equations of Dialysis John A. Sweeny john@sweenyfamily.net 1 An Equation is Math: A statement that each of two statements are equal to each other. Y 2 = 3x 3 + 2x + 7 Chemistry: A symbolic expression
More informationNon-Adherence: How to Improve the Therapeutic Relationship with Difficult Patients
Non-Adherence: How to Improve the Therapeutic Relationship with Difficult Patients Bradford Strijack MD MHSc FRCPC Clinical Assistant Professor University of British Columbia October 7, 2016 None Disclosures
More informationNATIONAL QUALITY FORUM Renal EM Submitted Measures
NATIONAL QUALITY FORUM Renal EM Submitted Measures Measure ID/ Title Measure Description Measure Steward Topic Area #1662 Percentage of patients aged 18 years and older with a diagnosis of CKD ACE/ARB
More informationDialysis Adequacy (HD) Guidelines
Dialysis Adequacy (HD) Guidelines Peter Kerr, Convenor (Monash, Victoria) Vlado Perkovic (Camperdown, New South Wales) Jim Petrie (Woolloongabba, Queensland) John Agar (Geelong, Victoria) Alex Disney (Woodville,
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Biochemical Targets. Calcium GUIDELINES
Date written: August 2005 Final submission: October 2005 Author: Carmel Hawley Biochemical Targets CARMEL HAWLEY (Woolloongabba, Queensland) GRAHAME ELDER (Westmead, New South Wales) Calcium GUIDELINES
More informationPrevalence, Predictors and Correlates of Non-Adherence to a Hemodialysis Regimen: A Review of the Literature
11 Prevalence, Predictors and Correlates of Non-Adherence to a Hemodialysis Regimen: A Review of the Literature Cynthia L. Russell, PhD, RN, University of Missouri-Columbia, Sinclair School of Nursing
More informationControl of hyperphosphatemia is a major goal in patients
ORIGINAL ARTICLES Phosphorus Clearance Using Two Hemodialyzers Placed in Parallel Mitchell H. Rosner, 1,2 Allen Helmandollar, 1 Ryan Evans, 1 Emaad Abdel-Rahman 1 Division of Nephrology, 1 University of
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More information[1] Levy [3] (odds ratio) 5.5. mannitol. (renal dose) dopamine 1 µg/kg/min atrial natriuretic peptide (ANP)
[1] Levy [3] 183 174 (odds ratio) 5.5 Woodrow [1] 1956 1989 mannitol (renal dose) dopamine 1 µg/kg/min atrial natriuretic peptide (ANP) McCarthy [2] 1970 1990 insulin-like growth factor-1 (IGF-1) ANP 92
More informationIN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006
IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 5 and 6] MAKE
More informationPhosphate binders and metabolic acidosis in patients undergoing maintenance hemodialysis sevelamer hydrochloride, calcium carbonate, and bixalomer
Hemodialysis International 2015; 19:5459 Phosphate binders and metabolic acidosis in patients undergoing maintenance hemodialysis sevelamer hydrochloride, calcium carbonate, and bixalomer Toru SANAI, 1
More informationNon-adherence in patients on chronic hemodialysis: an international comparison study
ORIGINAL ARTICLE JN EPHROL 00( 0000; 00) : 000-000 www.sin-italy.org/jnonline www.jnephrol.com Non-adherence in patients on chronic hemodialysis: an international comparison study Christiane Kugler 1,
More informationPrevalence of Access Recirculation in Prevalent Arterio-Venous (A-V) Fistula Hemodialysis Patients and Its Effect on Hemodialysis Adequacy
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 72 (6), Page 4602-4609 Prevalence of Access Recirculation in Prevalent Arterio-Venous (A-V) Fistula Hemodialysis Patients and Its Effect on Hemodialysis
More informationEvaluation and management of nutrition in children
Evaluation and management of nutrition in children Date written: May 2004 Final submission: January 2005 Author: Elisabeth Hodson GUIDELINES No recommendations possible based on Level I or II evidence
More informationTHE CURRENT PARADIGM of thrice-weekly
Dose of Dialysis: Key Lessons From Major Observational Studies and Clinical Trials Rajiv Saran, MD, MS, Bernard J. Canaud, MD, Thomas A. Depner, MD, Marcia L. Keen, PhD, Keith P. McCullough, MS, Mark R.
More informationTRANSPARENCY COMMITTEE OPINION. 22 July 2009
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 22 July 2009 PHOSPHOSORB 660 mg, film-coated tablet Container of 200 (CIP: 381 466-0) Applicant: FRESENIUS MEDICAL
More informationIN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2001
IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2001 [Before completing please read instructions at the bottom of this page and on pages 4 and 5] PATIENT IDENTIFICATION MAKE
More informationClinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet:
Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: Results of a prospective randomized controlled study Forni Valentina¹, Pruijm Menno¹,
More information2.0 Synopsis. ABT-358 M Clinical Study Report R&D/06/099. (For National Authority Use Only) to Item of the Submission: Volume:
2.0 Synopsis Abbott Laboratories Name of Study Drug: Zemplar Injection Name of Active Ingredient: Paricalcitol Individual Study Table Referring to Item of the Submission: Volume: Page: (For National Authority
More informationChapter 2 Peritoneal Equilibration Testing and Application
Chapter 2 Peritoneal Equilibration Testing and Application Francisco J. Cano Case Presentation FW, a recently diagnosed patient with CKD Stage 5, is a 6-year-old boy who has been recommended to initiate
More informationAna Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto
Ana Paula Bernardo CHP Hospital de Santo António ICBAS/ Universidade do Porto Clinical relevance of hyperphosphatemia Phosphate handling in dialysis patients Phosphate kinetics in PD peritoneal phosphate
More informationNormal kidneys filter large amounts of organic
ORIGINAL ARTICLE - NEPHROLOGY Effect Of Lanthanum Carbonate vs Calcium Acetate As A Phosphate Binder In Stage 3-4 CKD- Treat To Goal Study K.S. Sajeev Kumar (1), M K Mohandas (1), Ramdas Pisharody (1),
More informationHemodialysis is a life-sustaining procedure for the treatment of
The Dialysis Prescription and Urea Modeling Biff F. Palmer Hemodialysis is a life-sustaining procedure for the treatment of patients with end-stage renal disease. In acute renal failure the procedure provides
More informationPatients and Machines. NANT Annual National Symposium Wednesday March 9 th, 2011
Patients and Machines John A Sweeny John A. Sweeny NANT Annual National Symposium Wednesday March 9 th, 2011 Caroline Helm Caroline Helm was the first homepatient in the United States. She was a patient
More informationPREVALENCE AND CONSEQUENCES OF NONADHERENCE TO HEMODIALYSIS REGIMENS. Renal Issues in Critical Care. 1.5 Hours
Renal Issues in Critical Care PREVALENCE AND CONSEQUENCES OF NONADHERENCE TO HEMODIALYSIS REGIMENS By Kris Denhaerynck, RN, PhD, Dominique Manhaeve, MNS, Fabienne Dobbels, PhD, Daniela Garzoni, MD, Christa
More informationCSI (Clinical Scenario Investigation): Hyperkalemia
CSI (Clinical Scenario Investigation): Hyperkalemia Alison Thomas, RN(EC), MN, CNeph(C) Ann Jones, RN(EC), MSN, CNeph(C) Joyce Hunter, RN, Vascular Access Co-ordinator Simcoe Muskoka Regional Kidney Care
More informationCalcium x phosphate product
Date written: August 2005 Final submission: October 2005 Author: Carmel Hawley Calcium x phosphate product GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL
More informationPREVALENCE AND TYPES OF INTRA-DIALYTIC COMPLICATIONS IN PATIENTS DIALYSING AT THE UNIVERSITY OF BENIN TEACHING HOSPITAL
PREVALENCE AND TYPES OF INTRA-DIALYTIC COMPLICATIONS IN PATIENTS DIALYSING AT THE UNIVERSITY OF BENIN TEACHING HOSPITAL ADEJUMO OA, OLOKOR AB, IYAWE IO, OKAKA EI, UNUIGBE EI, OJOGWU LI Presented at Nigerian
More informationClinical Performance Goals
Clinical Performance Goals 2011-2012 Clinical Performance Goals 2011-2012 Table of Contents Table of Contents... 1 Health Care Quality Improvement Program... 2 Clinical Performance Measures... 6 Chapter
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES
Date written: August 2004 Final submission: July 2005 Monitoring patients on peritoneal dialysis GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions
More informationGlycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy
Nephrol Dial Transplant (2008) 23: 315 320 doi: 10.1093/ndt/gfm639 Advance Access publication 23 October 2007 Original Article Glycaemic control and serum intact parathyroid hormone levels in diabetic
More informationi. Where is the participant seen?
PFU01 method used: Phone/in-person interview 1 Enter PIP # here: Online survey 2 Enter Web # here: Initials of person completing form: Date Form Completed: / / Form Version: 03 / 01 / 18 Is the participant
More informationMedication burden in CKD-5D: impact of dialysis modality and setting
Clin Kidney J (2014) 7: 557 561 doi: 10.1093/ckj/sfu091 Advance Access publication 11 September 2014 Clinical Research Medication burden in CKD-5D: impact of dialysis modality and setting Kathrine Parker,
More informationHEALTHYSTART TRAINING MANUAL. Living well with Kidney Disease
HEALTHYSTART TRAINING MANUAL Living well with Kidney Disease KIDNEY DISEASE CAN AFFECT ANYONE! 1 HEALTHYSTART PROGRAMME HEALTHYSTART is a lifestyle management programme to assist you to remain healthy
More informationOld Dialysis Technical Guy
John A. Sweeny Old Dialysis Technical Guy 1 WHAT IS UREA? A compound formed in the liver by the process known as the urea cycle. Gram Molecular Weight = 60 Daltons Carbon - Oxygen - Nitrogen - Hydrogen
More informationThere are no shortcuts to Dialysis
There are no shortcuts to Dialysis 1 Outcomes John Sweeny Wednesday, March 21 st, 2018 (3:10 pm 4:10 pm) 2 Quality in Hemodialysis Quality Health Care is the degree to which health services increases the
More informationEffects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients. Hamid Nasri 1, Soleiman Kheiri 2
Saudi J Kidney Dis Transplant 2008;19(4):608-613 2008 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Original Article Effects of Diabetes Mellitus, Age, and
More informationYing-Ping Sun, Wen-Jun Yang, Su-Hua Li, Yuan-yuan Han, and Jian Liu
Hindawi BioMed Research International Volume 2017, Article ID 2516934, 5 pages https://doi.org/10.1155/2017/2516934 Research Article Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent
More informationYing Liu, 1 Wen-Chin Lee, 2 Ben-Chung Cheng, 2 Lung-Chih Li, 2 Chih-Hsiung Lee, 2 Wen-Xiu Chang, 1 and Jin-Bor Chen 2. 1.
BioMed Research International Volume 2016, Article ID 1523124, 7 pages http://dx.doi.org/10.1155/2016/1523124 Research Article Association between the Achievement of Target Range CKD-MBD Markers and Mortality
More informationClinical Guideline Bone chemistry management in adult renal patients on dialysis
Clinical Guideline Bone chemistry management in adult renal patients on dialysis This guidance covers how to: Maintain serum phosphate 0.8 to 1.7mmol/L 1 Maintain serum corrected calcium 2.1 to 2.5mmol/L
More informationRenal Association Clinical Practice Guideline in Mineral and Bone Disorders in CKD
Nephron Clin Pract 2011;118(suppl 1):c145 c152 DOI: 10.1159/000328066 Received: May 24, 2010 Accepted: December 6, 2010 Published online: May 6, 2011 Renal Association Clinical Practice Guideline in Mineral
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. Blood urea sampling methods GUIDELINES
Date written: November 2004 Final submission: July 2005 Blood urea sampling methods GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR CLINICAL CARE (Suggestions are
More informationPART ONE. Peritoneal Kinetics and Anatomy
PART ONE Peritoneal Kinetics and Anatomy Advances in Peritoneal Dialysis, Vol. 22, 2006 Paul A. Fein, Irfan Fazil, Muhammad A. Rafiq, Teresa Schloth, Betty Matza, Jyotiprakas Chattopadhyay, Morrell M.
More information2017 KDIGO Guidelines Update
2017 KDIGO Guidelines Update Clinic for Hemodialysis Clinical Center University of Sarajevo 13 th Congress of the Balkan cities Association of Nephrology, Dialysis, and Artificial Organs Transplantation
More informationPhil. J. Internal Medicine, 47: 19-23, Jan.-Feb., 2009
Original Articles Assessment of Hemodialysis Adequacy 19 Phil. J. Internal Medicine, 47: 19-23, Jan.-Feb., 2009 ASSESSMENT OF HEMODIALYSIS ADEQUACY: IONIC DIALYSANCE IN COMPARISON TO STANDARD METHOD KT/V-MAKATI
More informationNoncompliance with Treatment among Psychiatric Patients in Kuwait
Original Paper Med Principles Pract 1998;7:28 32 Received: December 12, 1996 Revised: March 22, 1997 Abdullahi A. Fido Abdulrazik M. Husseini Faculty of Medicine, Kuwait University, Kuwait Noncompliance
More informationInterdialytic weight gain and survival in hemodialysis patients: Effects of duration of ESRD and diabetes mellitus
Kidney International, Vol. 57 (2000), pp. 1141 1151 Interdialytic weight gain and survival in hemodialysis patients: Effects of duration of ESRD and diabetes mellitus PAUL L. KIMMEL, MARIA P. VARELA, ROLF
More informationDIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE. Jules B. Puschett, M.D.
DIAGNOSIS AND MANAGEMENT OF DIURETIC RESISTANCE Jules B. Puschett, M.D. Diuretic Resistance A clinical circumstance in which patients do not respond to a combination of salt restriction and even large
More informationEnd stage renal disease and Protein Energy wasting
End stage renal disease and Protein Energy wasting Dr Goh Heong Keong MBBS,MRCP(UK) www.passpaces.com/kidney.htm Introduction Chronic kidney disease- increasing health burden in many countries. The estimated
More informationIntradialytic Parenteral Nutrition in Hemodialysis Patients. Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia
Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy Amin, Pharm.D., MBA, BCNSP Riyadh, Saudi Arabia Disclosure Information Intradialytic Parenteral Nutrition in Hemodialysis Patients Hamdy
More informationApplying clinical guidelines treating and managing CKD
Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012
More informationThe impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure
Nephrol Dial Transplant (2002) 17: 340 345 The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure Naseem Amin Genzyme Corporation, Cambridge, MA,
More informationSystem Dynamics Highlights the Effect of Maintenance on Hemodialysis Performance
System Dynamics Highlights the Effect of Maintenance on Hemodialysis Performance Ahmad Taher Azar 1 Assistant Instructor, Systems and Biomedical Engineering Department Higher Technological Institute, Tenth
More informationA Study of substance abuse among chronic kidney disease patients having psychiatric illness undergoing haemodialysis
International Journal of Multidisciplinary and Current Research Research Article ISSN: 2321-3124 Available at: http://ijmcr.com A Study of substance among chronic kidney disease patients having psychiatric
More informationDiabetic Kidney Disease: An Overview of Evidence Based Guidelines and New Approaches to Application of Nutrition Therapy
Lesson Plans Diabetic Kidney Disease: An Overview of Evidence Based Guidelines and New Approaches to Application of Nutrition Therapy Review basic renal function and use this article to discuss key components
More informationPART FOUR. Metabolism and Nutrition
PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 22, 2006 Costas Fourtounas, Eirini Savidaki, Marilena Roumelioti, Periklis Dousdampanis, Andreas Hardalias, Pantelitsa Kalliakmani,
More informationEnd Stage Renal Disease and Nonadherence to Hemodialysis: Evaluation of a Psychodynamic Intervention
21 End Stage Renal Disease and Nonadherence to Hemodialysis: Evaluation of a Psychodynamic Intervention Anthony Mazzella, Institute for Psychoanalytic Training and Research (IPTAR), New York, NY; Cathy
More informationEffects of Hemodialysis on Circulating Adrenomedullin Concentrations in Patients with End-Stage Renal Disease
Original Paper Blood Purif 1998;16:269 274 Accepted: September 23, 1998 M. Toepfer a M. Schlosshauer b T. Sitter a C. Burchardi a T. Behr c H. Schiffl a Departments of a Nephrology, b Clinical Pharmacology,
More informationDiacap. Constant performance resulting in high quality dialysis. Avitum
Diacap Constant performance resulting in high quality dialysis Avitum B. Braun Avitum. Always with Passion. B. Braun is a leading international company in the healthcare market. With a long tradition stretching
More informationVariable Included. Excluded. Included. Excluded
Table S1. Baseline characteristics of patients included in the analysis and those excluded patients because of missing baseline serumj bicarbonate levels, stratified by dialysis modality. Variable HD patients
More informationImplementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018
Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018 Objectives By the end of this session the learner will
More informationMalnutrition in advanced CKD
Malnutrition in advanced CKD Malnutrition Lack of proper nutrition, caused by not having enough to eat, not eating enough of the right things or being unable to use the food that one does eat Jessica Stevenson
More informationBrief communication (Original)
Asian Biomedicine Vol. 8 No. 1 February 2014; 67-73 DOI: 10.5372/1905-7415.0801.263 Brief communication (Original) Long-term clinical effects of treatment by daytime ambulatory peritoneal dialysis with
More informationChronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol
Nutrition and Dietetic Service Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Dietetic Management Protocol Authors Hilary Mathieson, Renal Dietitian Paul McKeveney, Consultant Nephrologist
More information17 th Annual Meeting of JSHDF, Sept 3-4, 2011
17 th Annual Meeting of JSHDF, Sept 3-4, 2011 Sug Kyun Shin 1, JY Moon 2, SW Han 3, DH Yang 4, SH Lee 2, HC Park 5, JK Kim 6 and YI Jo 7 1 Nephrology, NHIC Ilsan Hospital, 2 Kyunghee University Hospital
More informationPrevalence of depression among patients with end stage renal disease
Orginal Article Prevalence of depression among patients with end stage renal disease 1 2 3 Trupti Bodhare, Vidhya Wilson, Sandeep D 1 2 Professor, Department of Community Medicine, Associate Professor,
More informationObjectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives
The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA
More informationDifferences in intermediate outcomes for Asian and non-asian adult hemodialysis patients in the United States
Kidney International, Vol. 64 (2003), pp. 623 631 Differences in intermediate outcomes for Asian and non-asian adult hemodialysis patients in the United States DIANE L. FRANKENFIELD, SYLVIA P.B. RAMIREZ,
More informationGeriatric Nutritional Risk Index, home hemodialysis outcomes 131
Subject Index Aksys PHD system 113 Anemia, home outcomes 111, 172, 173 Automated peritoneal dialysis dialysis comparison 17, 18 selection factors 18, 19 telemedicine system 19 21 Blood pressure -peritoneal
More informationAre Observational Studies Just as Effective as Randomized Clinical Trials?
Blood Purif 2000;18:317 322 Are Observational Studies Just as Effective as Randomized Clinical Trials? Tom Greene Department of Biostatistics and Epidemiology/Wb4, The Cleveland Clinic Foundation, Cleveland,
More information21th Budapest Nephrology School Ágnes Haris, Kálmán Polner
21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 53 years old female, -worked as computer scientist, -lived with her husband and 2 children, -in excellent financial situation. Diagnosed with
More informationCommission of Dietetic Registration Board Certified Specialist in Renal Nutrition Certification Examination Content Outline
I. Nutrition Assessment and Re-assessment (36%) A. Food/Nutrition-Related History 1. Evaluate current nutrition intake, losses, and nutrient adequacy. 2. Assess nutritional needs related to ethnic and
More informationApril 18, Dear Mr. Blum and Dr. Conway:
April 18, 2014 Dear Mr. Blum and Dr. Conway: On behalf of the undersigned patient and health professional organizations, thank you for meeting with us Wednesday, September 18, 2013. Our organizations were
More informationThe effects of an individual, multistep intervention on adherence to treatment in hemodialysis patients
http://informahealthcare.com/dre ISSN 0963-8288 print/issn 1464-5165 online Disabil Rehabil, Early Online: 1 5! 2015 Informa UK Ltd. DOI: 10.3109/09638288.2015.1061601 RESEARCH PAPER The effects of an
More informationFND 431 Clinical Experience Case Study! Introduction!
FND 431 Clinical Experience Case Study Jennifer Millard Introduction Ms. B is a Type II diabetic with ESRD who has been receiving dialysis since April of 2013. Previously, she has shown excellent compliance
More informationHYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY
UK RENAL PHARMACY GROUP SUBMISSION TO THE NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE on CINACALCET HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE
More informationClinical Performance Goals
Clinical Performance Goals 2012-2013 Clinical Performance Goals 2012-2013 Table of Contents Table of Contents... 1 Health Care Quality Improvement Program... 2 ESRD Quality Incentive Program (QIP)... 5
More informationGuidelines for the psychological management of chronic kidney disease patients (for the Psychologist)
Indian J Nephrol 2005;15, Supplement 1: S103-S108 S 103 Guidelines for the psychological management of chronic kidney disease patients (for the Psychologist) Introduction With increasing levels of sophistication
More informationEvidence Table. Study Type: Randomized controlled trial. Study Aim: To compare frequent nocturnal hemodialysis and conventional in-center dialysis.
Evidence Table Clinical Area: Reference: Frequent home dialysis Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass
More informationUnderstanding. Your Kidneys. Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016
Understanding Your Kidneys Laurie Biel, RN,BSN, CNN The MGH Center For Renal Education March 28, 2016 Today s Discussion - The Role of your kidneys Common causes of kidney disease Treatment for kidney
More informationHaemodialysis Blood Results
Haemodialysis Blood Results Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient information leaflets.htm Introduction
More informationStudy on quality of life of chronic kidney disease stage 5 patients on hemodialysis Gyawali M, Paudel HC, Chhetri PK, Shankar PR, Yadav SK
JMCJMS Research article Study on quality of life of chronic kidney disease stage 5 patients on hemodialysis Gyawali M, Paudel HC, Chhetri PK, Shankar PR, Yadav SK JF Institute of Health Science/LACHS Hattiban
More informationTABLE OF CONTENTS T-1. A-1 Acronyms and Abbreviations. S-1 Stages of Chronic Kidney Disease (CKD)
A-1 Acronyms and Abbreviations TABLE OF CONTENTS S-1 Stages of Chronic Kidney Disease (CKD) Chapter 1: Nutrition Assessment Charts, Tables and Formulas 1-2 Practical Steps to Nutrition Assessment Adult
More informationThe Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page
The Egyptian Journal of Hospital Medicine (October 2017) Vol.69(1), Page 1589-1594 Using Serum Beta Trace Protein to Estimate Residual Kidney Function in Hemodialysis Patients Hesham M. El-Sayed, Hussein
More informationGuidelines for the Management of Nutrition
S 42 Indian Journal of Nephrology Introduction Protein-energy malnutrition (PEM) is very common among patients with advanced chronic kidney disease (CKD). In the Indian scenario, where malnutrition is
More informationThe Effect of High-Flux Hemodialysis on Dialysis-Associated Amyloidosis
Renal Failure, 1:31-34, 2005 Copyright 2005 Taylor & Francis Inc. ISSN: 0886-022X print / 1525-6049 online DOI: 10.1081/JDI-200042868 Taylor & Francis Taylor 6. Francis Croup CLINICAL STUDY The Effect
More information3/21/2017. Solute Clearance and Adequacy Targets in Peritoneal Dialysis. Peritoneal Membrane. Peritoneal Membrane
3/21/2017 Solute Clearance and Adequacy Targets in Peritoneal Dialysis Steven Guest MD Director, Medical Consulting Services Baxter Healthcare Corporation Deerfield, IL, USA Peritoneal Membrane Image courtesy
More informationRisk factors for increased variability in dialysis delivery in haemodialysis patients
Nephrol Dial Transplant (2003) 18: 2112 2117 DOI: 10.1093/ndt/gfg297 Original Article Risk factors for increased variability in dialysis delivery in haemodialysis patients K. Scott Brimble, Darin J. Treleaven,
More informationNephrology. Renal Replacement in End-Stage Renal Disease Patients over 75 Years Old. ABC Fax
American Journal of Nephrology Original Article: Basic Sciences Am J Nephrol 2003;23:7 77 DOI: 0.59/000068040 Received: July 23, 2002 Accepted: October 2, 2002 Renal Replacement in End-Stage Renal Disease
More information